Inactive Instrument

Analyst Reco. Strongbridge Biopharma

Equities

STRONGBRIDGE BIOPHARMA : Oppenheimer Downgrades Strongbridge Biopharma to Not Rated From Outperform	21-06-21	MT
STRONGBRIDGE BIOPHARMA : Craig-Hallum Cuts Strongbridge Biopharma to Hold From Buy, Price Target to $3.25 From $9	21-05-25	MT
STRONGBRIDGE BIOPHARMA : JMP Securities Downgrades Strongbridge Biopharma to Market Perform From Market Outperform	21-05-25	MT
STRONGBRIDGE BIOPHARMA : Oppenheimer Adjusts Strongbridge Biopharma's Price Target to $8 From $7, Maintains Outperform Rating	20-11-12	MT

No results for this search